• 1
    Meyer, M. A. (2008) Malignant gliomas in adults. N. Engl. J. Med. 359, 1850; author reply 1850.
  • 2
    Buonerba, C., Di Lorenzo, G., Marinelli, A., Federico, P., Palmieri, G., et al. (2011) A comprehensive outlook on intracerebral therapy of malignant gliomas. Crit. Rev. Oncol./Hematol. 80, 5468.
  • 3
    Sherman, J. H., Hoes, K., Marcus, J., Komotar, R. J., Brennan, C. W., et al. (2011) Neurosurgery for brain tumors: update on recent technical advances. Curr. Neurol. Neurosci. Rep. 11, 313319.
  • 4
    Castro, M. G., Candolfi, M., Kroeger, K., King, G. D., Curtin, J. F., et al. (2011) Gene therapy and targeted toxins for glioma. Curr. Gene Ther. 11, 155180.
  • 5
    Filipek, A., and Wojda, U. (1996) p30, a novel protein target of mouse calcyclin (S100A6). Biochem. J. 320 (Part 2), 585587.
  • 6
    Filipek, A., and Kuznicki, J. (1998) Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 70, 17931798.
  • 7
    Matsuzawa, S. I., and Reed, J. C. (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell 7, 915926.
  • 8
    Filipek, A., Jastrzebska, B., Nowotny, M., and Kuznicki, J. (2002) CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J. Biol. Chem. 277, 2884828852.
  • 9
    Schneider, G., Nieznanski, K., Jozwiak, J., Slomnicki, L. P., Redowicz, M. J., et al. (2010) Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. Biochim. Biophys. Acta 1803, 13081317.
  • 10
    Kilanczyk, E., Filipek, S., Jastrzebska, B., and Filipek, A. (2009) CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. Biochem. Biophys. Res. Commun. 380, 5459.
  • 11
    Xia, Z. B., Dai, M. S., Magoulas, C., Broxmeyer, H. E., and Lu, L. (2000) Differentially expressed genes during in vitro differentiation of murine embryonic stem cells transduced with a human erythropoietin receptor cDNA. J. Hematother. Stem Cell Res. 9, 651658.
  • 12
    Pircher, T. J., Geiger, J. N., Zhang, D., Miller, C. P., Gaines, P., et al. (2001) Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J. Biol. Chem. 276, 89959002.
  • 13
    Au, K. W., Kou, C. Y., Woo, A. Y., Chim, S. S., Fung, K. P., et al. (2006) Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J. Cell. Biochem. 98, 555566.
  • 14
    Chen, X., Han, G., Zhai, H., Zhang, F., Wang, J., et al. (2008) Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology 8, 470477.
  • 15
    Zhai, H., Shi, Y., Jin, H., Li, Y., Lu, Y., et al. (2008) Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J. Histochem. Cytochem. 56, 765772.
  • 16
    Herington, J. L., Bi, J., Martin, J. D., and Bany, B. M. (2007) β-Catenin (CTNNB1) in the mouse uterus during decidualization and the potential role of two pathways in regulating its degradation. J. Histochem. Cytochem. 55, 963974.
  • 17
    Chen, X., Mo, P., Li, X., Zheng, P., Zhao, L., et al. (2011) CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol. Carcinog. 50, 804810.
  • 18
    Ning, X., Sun, S., Hong, L., Liang, J., Liu, L., et al. (2007) Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol. Cancer Res. 5, 12541262.
  • 19
    Mezhybovska, M., Wikstrom, K., Ohd, J. F., and Sjolander, A. (2006) The inflammatory mediator leukotriene D4 induces β-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J. Biol. Chem. 281, 67766784.
  • 20
    Sangkhathat, S., Kusafuka, T., Miao, J., Yoneda, A., Nara, K., et al. (2006) In vitro RNA interference against β-catenin inhibits the proliferation of pediatric hepatic tumors. Int. J Oncol. 28, 715722.
  • 21
    Vousden, K. H., and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275283.
  • 22
    Levine, A. J., and Oren, M. (2009) The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9, 749758.